Welcome to our dedicated page for Quantumcore news (Ticker: QNCRF), a resource for investors and traders seeking the latest updates and insights on Quantumcore stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quantumcore's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quantumcore's position in the market.
QuantumCore (QNCRF) has completed its acquisition of 100% of Avalanche PhotoniQ, adding a foundry-ready single-photon detector platform, effective under a September 9, 2026 share purchase agreement.
The deal creates two core technology platforms for QuantumCore: superconducting traveling-wave parametric amplifiers for cryogenic quantum signal amplification, and Avalanche’s advanced single-photon detectors based on proprietary semiconductor metasurface technology. The acquired assets include Avalanche’s intellectual property portfolio and a detector design prepared for commercial foundry manufacturing, which QuantumCore plans to move into production and customer evaluation.
Transaction terms comprise a C$2.0 million purchase price (C$1.07 million cash at closing and a C$930,000 milestone tied to 100 qualifying detectors), plus a one-time C$1.0 million earn-out if C$1.0 million in annual net revenue is achieved.
QuantumCore (QNCRF) announced that its common shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC).
DTC eligibility is expected to simplify U.S. trading, streamline settlement, and expand access to QuantumCore shares across a wider network of brokerage firms.
QuantumCore (QNCRF) will participate as a Gold Sponsor at IEEE Quantum Week 2026, the IEEE International Conference on Quantum Computing and Engineering, held September 13-18, 2026 in Toronto, Canada.
The event is described as a major global gathering for researchers, developers, businesses and institutions advancing quantum technologies. QuantumCore plans to use its sponsorship to showcase its strategy of building a portfolio of quantum infrastructure technologies that support current quantum computing roadmaps, rather than developing its own quantum processing units.
The company highlights its superconducting traveling-wave parametric amplifier platform for quantum-limited signal amplification in cryogenic environments, as well as advanced single-photon detector technologies for potential use in photonic quantum computing, quantum communications and quantum networking.
QuantumCore (CSE: QNCR; FSE: K1Y; OTC: QNCRF) closed the second and final tranche of its non-brokered private placement, raising additional gross proceeds of $426,000. In total, the Company issued 2,556,945 common shares at $2.00 per share for aggregate gross proceeds of $5,113,890, to be used for general corporate and working capital purposes.
All shares are subject to a four-month-and-one-day hold period under Canadian securities laws. QuantumCore also amended its investor awareness agreement with Altura Media, adding a $420,000 budget for continued digital investor marketing, subject to Canadian Securities Exchange acceptance.
QuantumCore (CSE: QNCR, FSE: K1Y; QNCRF) closed an upsized first tranche of its previously announced non-brokered private placement, issuing 2,343,945 common shares at C$2.00 per share for gross proceeds of C$4,687,890. The total Offering has been increased from C$4,269,600 to up to C$5,113,890, with a second tranche of C$426,000 expected to close on or about August 18, 2026, mainly from existing shareholders, subject to customary conditions and Canadian Securities Exchange approval.
According to QuantumCore, net proceeds will be used for general corporate and working capital purposes. All shares will carry a hold period of four months and one day under Canadian securities laws, and the securities are not registered under the U.S. Securities Act.
QuantumCore (CSE: QNCR, OTC: QNCRF) announced a non-brokered private placement with a new U.S.-based strategic investor for up to C$4.27 million. The investor has agreed to purchase 2,134,800 common shares at C$2.00 per share, for gross proceeds of C$4,269,600, expected to close on or about August 7, 2026, subject to regulatory approvals.
According to QuantumCore, the financing should lift its cash position to over C$10 million and underpin a long-term strategic partnership. Proceeds are earmarked for product commercialization, R&D expansion, manufacturing scale-up, and strategic acquisitions. The investor receives participation rights to maintain pro rata ownership in future financings until at least August 6, 2029, while holding 100,000+ shares.
QuantumCore (CSE: QNCR, OTCQB: QNCRF, FSE: K1Y) will present at Canaccord Genuity's 46th Annual Growth Conference in Boston, held August 11-13, 2026. The Company is scheduled to present on Wednesday, August 12, 2026, at 3:30 p.m. EDT, led by CEO Eugene Profis and CTO Dr. Christopher Wilson.
Management will update investors on QuantumCore's technology roadmap, commercialization strategy, and advances in its quantum amplifiers, room‑temperature single-photon detector platform, and cryogenic multiplexing technologies, and will also participate in one‑on‑one meetings with investors and strategic partners.
QuantumCore (CSE: QNCR, OTCQB: QNCRF, FSE: K1Y) has filed articles of continuance to move its corporate jurisdiction from Alberta to Ontario under the Business Corporations Act (Ontario). Shareholders approved the continuance on July 20, 2026, with an effective date of July 22, 2026. A Certificate of Continuance is available on SEDAR+. QuantumCore develops critical quantum computing infrastructure, including superconducting amplification, cryogenic signal processing, and advanced quantum hardware solutions.
QuantumCore (CSE: QNCR, OTCQB: QNCRF) announced a Memorandum of Understanding with Professor Raafat Mansour of the University of Waterloo to establish a strategic research and commercialization collaboration for advanced cryogenic multiplexing microchips for quantum computing.
The parties intend to jointly develop cryogenic switching, multiplexed qubit control and readout architectures, integrated microwave circuit designs, prototype fabrication and related intellectual property. QuantumCore plans to fund the launch of the program and pursue additional non-dilutive research support through Canadian innovation programs, aligning with its strategy to build a portfolio of enabling quantum infrastructure technologies and support Canada’s National Quantum Strategy.
QuantumCore (CSE: QNCR, OTCQB: QNCRF, FSE: K1Y) has been approved to trade on the OTCQB Venture Market, operated by OTC Markets Group, and began trading under symbol QNCRF on July 20, 2026. The company views this U.S. listing as a key step in its capital markets strategy, aiming to increase visibility among U.S. investors, improve trading accessibility via U.S. brokerage platforms, and potentially enhance liquidity.
QuantumCore will maintain its listings on the Canadian Securities Exchange (QNCR) and Frankfurt Stock Exchange (K1Y). The company develops quantum computing infrastructure technologies focused on superconducting amplification, cryogenic signal processing, and advanced quantum hardware for next-generation quantum computers and quantum networks.